160 related articles for article (PubMed ID: 38650629)
1. Effect of
Wang Y; Zhou Q; Wang H; Song W; Wang J; Mamun AA; Geng P; Zhou Y; Wang S
Front Pharmacol; 2024; 15():1351882. PubMed ID: 38650629
[TBL] [Abstract][Full Text] [Related]
2. Effects of bergapten on the pharmacokinetics of macitentan in rats both
Xu J; Zhou Q; Hou P; Wang Y; Geng P; Lu Z; Zhou Y; Dai D; Wang S
Front Pharmacol; 2023; 14():1204649. PubMed ID: 37492094
[TBL] [Abstract][Full Text] [Related]
3. A UPLC-MS/MS method for in vivo and in vitro pharmacokinetic studies of psoralenoside, isopsoralenoside, psoralen and isopsoralen from Psoralea corylifolia extract.
Wang YF; Liu YN; Xiong W; Yan DM; Zhu Y; Gao XM; Xu YT; Qi AD
J Ethnopharmacol; 2014; 151(1):609-17. PubMed ID: 24315982
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Baohuoside I on the Metabolism of Tofacitinib in Rats.
Shi Y; Lu Z; Song W; Wang Y; Zhou Q; Geng P; Zhou Y; Wang S; Han A
Drug Des Devel Ther; 2024; 18():931-939. PubMed ID: 38560524
[TBL] [Abstract][Full Text] [Related]
5. The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
Ye Z; Hu J; Wang J; Liu YN; Hu GX; Xu RA
Chem Biol Interact; 2023 Apr; 374():110398. PubMed ID: 36773832
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Xia M; Song X; Lu Z; Wang Y; Zhou Q; Geng P; Wang S; Zhou Y; Wu Q; Han A
Thorac Cancer; 2023 Nov; 14(33):3331-3341. PubMed ID: 37771131
[TBL] [Abstract][Full Text] [Related]
7. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
[TBL] [Abstract][Full Text] [Related]
8. CYP3A4 inhibition by
Liu Y; Flynn TJ
Toxicol Rep; 2015; 2():530-534. PubMed ID: 28962388
[No Abstract] [Full Text] [Related]
9. Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib
Zhou S; Zhao FL; Wang SH; Wang YR; Hong Y; Zhou Q; Geng PW; Luo QF; Cai JP; Dai DP
Pharm Biol; 2023 Dec; 61(1):356-361. PubMed ID: 36728978
[TBL] [Abstract][Full Text] [Related]
10. Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.
Bao SS; Tang PF; Gao NY; Xiao ZX; Qian JC; Zheng L; Hu GX; Xu HH
PeerJ; 2023; 11():e16051. PubMed ID: 37719112
[TBL] [Abstract][Full Text] [Related]
11. Studies on the inhibitory effect of isavuconazole on flumatinib metabolism
Liu YN; Xu X; Nie J; Hu Y; Xu X; Xu RA; Du X
Front Pharmacol; 2023; 14():1168852. PubMed ID: 37214442
[TBL] [Abstract][Full Text] [Related]
12. Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
Zhang XS; Ren W; Bian BL; Zhao HY; Wang S
Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1641-50. PubMed ID: 26467116
[TBL] [Abstract][Full Text] [Related]
13. [Determination and pharmacokinetics of main components for Psoralea corylifolia-Myristica fragrants drug pair by using UPLC-MS/MS].
Gao JR; Xu SZ; Han YQ; Wei LB; Jiang H; Song JM; Xue X
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1782-1786. PubMed ID: 29082707
[TBL] [Abstract][Full Text] [Related]
14. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
[TBL] [Abstract][Full Text] [Related]
15. Isolation and purification of psoralen and isopsoralen and their efficacy and safety in the treatment of osteosarcoma in nude rats.
Lu H; Zhang L; Liu D; Tang P; Song F
Afr Health Sci; 2014 Sep; 14(3):641-7. PubMed ID: 25352883
[TBL] [Abstract][Full Text] [Related]
16. CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism.
Ye Z; Xia H; Hu J; Liu YN; Wang A; Cai JP; Hu GX; Xu RA
Biomed Pharmacother; 2024 Jun; 175():116421. PubMed ID: 38719708
[TBL] [Abstract][Full Text] [Related]
17. Herb-drug interaction between Shaoyao-Gancao-Fuzi decoction and tofacitinib via CYP450 enzymes.
Lin L; Wang Y; Shao S; Lin W; Huang D; Dai Y; Xia Y
J Ethnopharmacol; 2022 Sep; 295():115437. PubMed ID: 35667582
[TBL] [Abstract][Full Text] [Related]
18. The effect of apatinib on pharmacokinetic profile of buspirone both in vivo and in vitro.
Zhang XD; Li YH; Chen DX; You WW; Hu XX; Chen BB; Hu GX; Qian JC
J Pharm Pharmacol; 2020 Oct; 72(10):1405-1411. PubMed ID: 32608074
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data.
Gupta P; Alvey C; Wang R; Dowty ME; Fahmi OA; Walsky RL; Riese RJ; Krishnaswami S
Br J Clin Pharmacol; 2012 Jul; 74(1):109-15. PubMed ID: 22233204
[TBL] [Abstract][Full Text] [Related]
20. The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
Zhou Q; Ye F; Ye Z; Gao N; Kong Q; Hu X; Qian J; Wu B
PeerJ; 2023; 11():e16601. PubMed ID: 38089912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
